DOCSLIB.ORG

Myod Prevents Cyclina/Cdk2 Containing E2F Complexes Formation in Terminally Di€Erentiated Myocytes

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Myod Prevents Cyclina/Cdk2 Containing E2F Complexes Formation in Terminally Di€Erentiated Myocytes Oncogene (1997) 14, 1171 ± 1184 1997 Stockton Press All rights reserved 0950 ± 9232/97 $12.00 MyoD prevents cyclinA/cdk2 containing E2F complexes formation in terminally dierentiated myocytes Pier Lorenzo Puri1,3, Clara Balsano2, Vito Lelio Burgio3, Paolo Chirillo1,3, Gioacchino Natoli1,3, Letizia Ricci4, Elisabetta Mattei4, Adolf Graessmann5 and Massimo Levrero1 1Fondazione A Cesalpino and 3I Clinica Medica, University of Rome `La Sapienza', Viale del Policlinico 155, 00161 Roma, Italy; 2Dipartimento di Medicina Interna, University of L'Aquila; 4Istituto di Tecnologie Biomediche CNR, Roma; 5Institute fur Molekularbiologie und Biochemie der Freien Universitat Berlin, 14195 Berlin, Germany Withdrawal from the cell cycle of dierentiating for myogenic dierentiation is the irreversible with- myocytes is regulated by the myogenic basic helix ± drawal from the cell cycle (Nadal-Ginard, 1978; loop ± helix (bHLH) protein MyoD and the pocket Stockdale and Holtzer, 1961). Master regulators of proteins pRb, p107 and pRb2/p130. Downstream muscle cell commitment and dierentiation are the eectors of `pocket' proteins are the components of the members of the MyoD family of myogenic basic E2F family of transcription factors, which regulate the Helix ± Loop ± Helix (bHLH) proteins (Lassar and G1/S-phase transition. We analysed by EMSA the Munstemberg, 1994; Olson and Klein, 1994), the composition of E2F complexes in cycling, quiescent retinoblastoma protein (pRb) (Gu et al., 1993) and undierentiated and dierentiated C2C12 skeletal muscle its related proteins p107 and pRb2/p130 (Mayol et al., cells. An E2F complex containing mainly E2F4 and 1993; Schneider et al., 1994; Shin et al., 1995). pRb2/p130 (E2F-G0/G1 complex) appears when DNA In conditions permissive for dierentiation, pRb synthesis arrests, replacing the cyclinA/cdk2 containing binds MyoD via a region overlapping the `pocket' E2F complex of proliferating myoblasts (E2F-G1/S region (Gu et al., 1993), a conserved domain, also complex). Serum stimulation reinduces DNA synthesis present in the pRb-related proteins p107 and pRb2/ and the re-appearance of E2F-G1/S complexes in p130 and required for binding with viral transforming quiescent myoblasts but not in dierentiated C2C12 proteins and the members of the E2F/DP family myotubes. In dierentiating C2C12 cells, E2F complexes (DeCaprio et al., 1988; Whyte et al., 1989; Dyson et switch and DNA synthesis in response to serum are al., 1990; LaThangue, 1994; Wolf et al., 1995). pRb also prevented when MyoD DNA binding activity and the binds and inactivates the ubiquitously expressed HLH cdks inhibitor MyoD downstream eector p21 are protein Id2 (Iavarone et al., 1994), which upon high induced. Thus, during myogenic dierentiation, forma- mitogens concentration sequestrates the E proteins and tion of E2F4 and pRb2/p130 containing complexes is an inhibits MyoD binding to the E-box (Benezra et al., early event, but not enough on its own to prevent the re- 1990). Like pRb, also p107 interacts with MyoD in a activation of DNA synthesis. Using a subclone of similar fashion, suggesting that redundance might exist C3H10T1/2 mouse ®broblasts stably expressing Estro- to ensure the dierentiation program under appropriate gen Receptor-MyoD (ER-MyoD) chimerae, we found conditions. However, pRb de®cient cells ± where p107 that estrogen directed MyoD activation prevents the re- myogenic functions are recruited, undergo phenotypic association of cyclinA/cdk2 to the E2F4 containing myogenic dierentiation, although retaining their ability complex following serum stimulation and this correlates to re-enter into the cell cycle in response to serum with suppression of E2F activity and the inability of cells stimulation (Schneider et al., 1994). This suggests that to re-enter the cell cycle. Our data indicate that, in pRb is critical to prevent DNA synthesis in differ- dierentiating myocytes, one mechanism through which entiated myotubes in response to mitogens. MyoD induces permanent cell cycle arrest involves p21 pRb's and the other `pocket' proteins role in the upregulation and suppression of the proliferation-asso- permanent exit from the cell cycle and terminal ciated cdks-containing E2F complexes formation. dierentiation is also suggested by the evidence that the products of the viral oncogenes, i.e. polyomavirus Keywords: MyoD; E2F; pRb2/p130; p21; cell cycle large T antigen, adenovirus E1A and SV40 large T antigens are all able to prevent dierentiation of both primary myoblasts and myogenic cell lines (Graess- mann et al., 1973; Webster et al., 1988; Braun et al., Introduction 1992; Maione et al., 1992, 1994; Caruso et al., 1993) and to reinduce DNA synthesis in C2C12 myotubes In vitro skeletal muscle dierentiation consists in (Endo et al., 1986; Cardoso et al., 1993; Crescenzi et mononucleated myoblasts fusion into multinucleated al., 1995). myotubes (phenotypical dierentiation) which express pRb and pRb-related proteins bind and negatively a coordinate set of muscle-speci®c genes (biochemical regulate the activity of E2F (Chellapan et al., 1991; dierentiation) (Olson and Klein, 1994). Prerequisite Hiebert et al., 1992; Weintraub et al., 1992; Cobrinik et al., 1993; Helin et al., 1993a; Zamanian and LaThangue, 1993; Tommasi and Pfeier, 1995). E2F Correspondence: PL Puri is a family of heterodimeric transcription factors made- Received 31 July 1996; revised 8 November 1996; accepted 8 up of E2F-like and DP-like subunits (LaThangue, November 1996 1994). Many genes involved in DNA replication and MyoD-mediated repression of E2Finmyocytes PL Puri et al 1172 cell proliferation that are sequentially activated during Results the cell cycle ± i.e. c-myc,c-myb, cdc2, thymidine kinase (tk), dihydrofolate reductase (DHFR) ± contain E2F complexes in cycling, G /G arrested and E2F binding sites in their regulatory region (LaThan- 0 1 dierentiated C2C12 cells gue, 1994; Nevins, 1992). At least seven genes encoding for components of the E2F family have been cloned C2C12 skeletal muscle cells were used to study the E2F (E2F from 1 to 5, DP1 and DP2) (Helin et al., 1992, complexes composition in dierent culture conditions. 1993b; Kaelin et al., 1992; Shan et al., 1992; Ivey- In high serum (20% FCS) C2C12 myoblasts actively Hoyle et al., 1993; Beijersbergen et al., 1994; Ginsberg proliferate, as demonstrated by high levels of 5-Bromo- et al., 1994; Li et al., 1994; Hijmans et al., 1995; Zhang 2 deoxy-Uridine (BrdU) incorporation (Figure 1A). and Chellapan, 1995). Multiple evidences indicate that Full dierentiation into mature multinucleated myo- E2F1 plays a critical role in regulating G1/S phase tubes is obtained by culturing con¯uent C2C12 cells in transition (Johnson et al., 1993; Sala et al., 1994; low serum (2% FCS; DM, dierentiation medium). Kowalik et al., 1995) and deregulated expression of C2C12 myotubes do not incorporate BrdU (Figure 1F) E2F1 leads to apoptosis in certain cell types (Shan and and display several muscle-speci®c markers, such as Lee, 1994; Qin et al., 1994). In muscle cells, E2F1 myosin heavy chain (MHC) (Figure 1C). When C2C12 overexpression inhibits myogenic dierentiation (Wang cells are kept in the absence of serum (0.1% FCS) et al., 1995). In association with DP1, E2F1 binds before con¯uence is reached, quiescent undierentiated underphosphorylated pRb and forms a complex which mononucleated myoblasts can be observed between 24 retains its DNA-binding property but is not able to and 48 h after starvation. These quiescent myoblasts activate transcription (Weintraub et al., 1992; Helin et do not incorporate BrdU (Figure 1E) and do not al., 1993a). In many cell types the pRb-E2F complex is express muscle speci®c markers (Figure 1B), although a minor component of the G0 E2F-DNA binding retaining the ability to proliferate in response to activity (Chittenden et al., 1993; Dou et al., 1994; mitogens (Puri et al., 1995). Schwarz et al., 1993). In unstimulated human T cells For gel retardation assays, cell extracts were and in growth arrested murine ®broblasts an E2F prepared from noncon¯uent C2C12 cells cultured in complex, formed by E2F4 and pRb2/p130, has been 20% serum enriched medium (cycling myoblasts), from detected (Cobrinik et al., 1993; Vairo et al., 1995). This noncon¯uent C2C12 cells cultured in 0.1% serum complex can play a role in inducing and/or maintaining (quiescent myoblasts) and from C2C12 dierentiated cellular quiescence (Claudio et al., 1994; Vairo et al., myotubes. We detected four E2F complexes whose 1995). Functional studies have demonstrated that formation is dierentially regulated along the cell cycle pRb2/p130 suppress E2F4 but not E2F1 mediated and during dierentiation (Figure 2a). The binding trans-activation and that E2F4 coexpression is able to speci®city of each E2F complex was con®rmed by overcome pRb2/p130 mediated G1 arrest more competition experiments with excess unlabelled wild eciently than Rb-induced G1 blockade (Vairo et al., type and mutant E2F speci®c oligonucleotides (Figure 1995). E2F4 also forms heterodimers with members of 2b) and unrelated unlabelled DNA (data not shown). the DP family and p107 (Beijersbergen et al., 1994; The slower migrating band (E2F-G1/S complex), Ginsberg et al., 1994), an association occurring in late detected in cycling myoblasts, disappears when cells G1 or at the G1/S boundary (Schwarz et al., 1993). In enter G0 (C2C12 quiescent) being replaced by a faster addition, both p107 and pRb2/p130 have been migrating band (the E2F-G0/G1 complex) also found in described to associate with cyclin E and A and their dierentiated C2C12 myotubes. Two additional faster dependent kinase cdk2 to form E2F-containing migrating bands were observed in all cell cycle phases, complexes in late G1 and S-phase, respectively but were more evident in cycling myoblasts then in (Devoto et al., 1992; Lees et al., 1992; Pagano et al., quiescent cells. Fully dierentiated myotubes display 1992; Hannon et al., 1993; Li et al., 1993). However, faster migrating bands similar in abundance to those the functional consequences of these multimeric detected in quiescent cells.
Load more

Recommended publications
  • Core Transcriptional Regulatory Circuitries in Cancer
    Oncogene (2020) 39:6633–6646 https://doi.org/10.1038/s41388-020-01459-w REVIEW ARTICLE Core transcriptional regulatory circuitries in cancer 1 1,2,3 1 2 1,4,5 Ye Chen ● Liang Xu ● Ruby Yu-Tong Lin ● Markus Müschen ● H. Phillip Koeffler Received: 14 June 2020 / Revised: 30 August 2020 / Accepted: 4 September 2020 / Published online: 17 September 2020 © The Author(s) 2020. This article is published with open access Abstract Transcription factors (TFs) coordinate the on-and-off states of gene expression typically in a combinatorial fashion. Studies from embryonic stem cells and other cell types have revealed that a clique of self-regulated core TFs control cell identity and cell state. These core TFs form interconnected feed-forward transcriptional loops to establish and reinforce the cell-type- specific gene-expression program; the ensemble of core TFs and their regulatory loops constitutes core transcriptional regulatory circuitry (CRC). Here, we summarize recent progress in computational reconstitution and biologic exploration of CRCs across various human malignancies, and consolidate the strategy and methodology for CRC discovery. We also discuss the genetic basis and therapeutic vulnerability of CRC, and highlight new frontiers and future efforts for the study of CRC in cancer. Knowledge of CRC in cancer is fundamental to understanding cancer-specific transcriptional addiction, and should provide important insight to both pathobiology and therapeutics. 1234567890();,: 1234567890();,: Introduction genes. Till now, one critical goal in biology remains to understand the composition and hierarchy of transcriptional Transcriptional regulation is one of the fundamental mole- regulatory network in each specified cell type/lineage.
    [Show full text]
  • P53 Regulates Myogenesis by Triggering the Differentiation
    CORE Metadata, citation and similar papers at core.ac.uk Provided by PubMed Central p53 Regulates Myogenesis by Triggering the Differentiation Activity of pRb Alessandro Porrello, Maria Antonietta Cerone, Sabrina Coen, Aymone Gurtner, Giulia Fontemaggi, Letizia Cimino, Giulia Piaggio, Ada Sacchi, and Silvia Soddu Molecular Oncogenesis Laboratory, Regina Elena Cancer Institute, Center for Experimental Research, 00158 Rome, Italy Abstract. The p53 oncosuppressor protein regulates mary myoblasts, pRb is hypophosphorylated and prolif- cell cycle checkpoints and apoptosis, but increasing evi- eration stops. However, these cells do not upregulate dence also indicates its involvement in differentiation pRb and have reduced MyoD activity. The transduction and development. We had previously demonstrated of exogenous TP53 or Rb genes in p53-defective myo- that in the presence of differentiation-promoting stim- blasts rescues MyoD activity and differentiation poten- uli, p53-defective myoblasts exit from the cell cycle but tial. Additionally, in vivo studies on the Rb promoter do not differentiate into myocytes and myotubes. To demonstrate that p53 regulates the Rb gene expression identify the pathways through which p53 contributes at transcriptional level through a p53-binding site. to skeletal muscle differentiation, we have analyzed Therefore, here we show that p53 regulates myoblast the expression of a series of genes regulated during differentiation by means of pRb without affecting its myogenesis in parental and dominant–negative p53 cell cycle–related functions. (dnp53)-expressing C2C12 myoblasts. We found that in dnp53-expressing C2C12 cells, as well as in p53Ϫ/Ϫ pri- Key words: p53 • Rb • MyoD • differentiation • muscle Introduction The differentiation of skeletal myoblasts is characterized review, see Wright, 1992).
    [Show full text]
  • Nuclear Localization of DP and E2F Transcription Factors by Heterodimeric Partners and Retinoblastoma Protein Family Members
    Journal of Cell Science 109, 1717-1726 (1996) 1717 Printed in Great Britain © The Company of Biologists Limited 1996 JCS7086 Nuclear localization of DP and E2F transcription factors by heterodimeric partners and retinoblastoma protein family members Junji Magae1, Chin-Lee Wu2, Sharon Illenye1, Ed Harlow2 and Nicholas H. Heintz1,* 1Department of Pathology, University of Vermont, Burlington VT 05405, USA 2Massachusetts General Hospital Cancer Center, Charlestown MA 02129, USA *Author for correspondence SUMMARY E2F is a family of transcription factors implicated in the showed that regions of E2F-1 and DP-1 that are required regulation of genes required for progression through G1 for stable association of the two proteins were also required and entry into the S phase. The transcriptionally active for nuclear localization of DP-1. Unlike E2F-1, -2, and -3, forms of E2F are heterodimers composed of one polypep- E2F-4 did not accumulate in the nucleus unless it was coex- tide encoded by the E2F gene family and one polypeptide pressed with DP-2. p107 and p130, but not pRb, stimulated encoded by the DP gene family. The transcriptional activity nuclear localization of E2F-4, either alone or in combina- of E2F/DP heterodimers is influenced by association with tion with DP-2. These results indicate that DP proteins the members of the retinoblastoma tumor suppressor preferentially associate with specific E2F partners, and protein family (pRb, p107, and p130). Here the intracellu- suggest that the ability of specific E2F/DP heterodimers to lar distribution of E2F and DP proteins was investigated in localize in the nucleus contributes to the regulation of E2F transiently transfected Chinese hamster and human cells.
    [Show full text]
  • Investigation of the Underlying Hub Genes and Molexular Pathogensis in Gastric Cancer by Integrated Bioinformatic Analyses
    bioRxiv preprint doi: https://doi.org/10.1101/2020.12.20.423656; this version posted December 22, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Investigation of the underlying hub genes and molexular pathogensis in gastric cancer by integrated bioinformatic analyses Basavaraj Vastrad1, Chanabasayya Vastrad*2 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India bioRxiv preprint doi: https://doi.org/10.1101/2020.12.20.423656; this version posted December 22, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract The high mortality rate of gastric cancer (GC) is in part due to the absence of initial disclosure of its biomarkers. The recognition of important genes associated in GC is therefore recommended to advance clinical prognosis, diagnosis and and treatment outcomes. The current investigation used the microarray dataset GSE113255 RNA seq data from the Gene Expression Omnibus database to diagnose differentially expressed genes (DEGs). Pathway and gene ontology enrichment analyses were performed, and a proteinprotein interaction network, modules, target genes - miRNA regulatory network and target genes - TF regulatory network were constructed and analyzed. Finally, validation of hub genes was performed. The 1008 DEGs identified consisted of 505 up regulated genes and 503 down regulated genes.
    [Show full text]
  • TP63 and TP73 in Cancer, an Unresolved В€Œfamily∕ Puzzle Of
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector FEBS Letters 588 (2014) 2590–2599 journal homepage: www.FEBSLetters.org Review TP63 and TP73 in cancer, an unresolved ‘‘family’’ puzzle of complexity, redundancy and hierarchy Antonio Costanzo a, Natalia Pediconi b,c, Alessandra Narcisi a, Francesca Guerrieri c,d, Laura Belloni c,d, ⇑ Francesca Fausti a, Elisabetta Botti a, Massimo Levrero c,d, a Dermatology Unit, Department of Neuroscience, Mental Health and Sensory Organs (NESMOS), Sapienza University of Rome, Italy b Laboratory of Molecular Oncology, Department of Molecular Medicine, Sapienza University of Rome, Italy c Center for Life Nanosciences (CNLS) – IIT/Sapienza, Rome, Italy d Laboratory of Gene Expression, Department of Internal Medicine (DMISM), Sapienza University of Rome, Italy article info abstract Article history: TP53 belongs to a small gene family that includes, in mammals, two additional paralogs, TP63 and Received 19 May 2014 TP73. The p63 and p73 proteins are structurally and functionally similar to p53 and their activity as Revised 16 June 2014 transcription factors is regulated by a wide repertoire of shared and unique post-translational mod- Accepted 16 June 2014 ifications and interactions with regulatory cofactors. p63 and p73 have important functions in Available online 28 June 2014 embryonic development and differentiation but are also involved in tumor suppression. The biology Edited by Shairaz Baksh, Giovanni Blandino of p63 and p73 is complex since both TP63 and TP73 genes are transcribed into a variety of different and Wilhelm Just isoforms that give rise to proteins with antagonistic properties, the TA-isoforms that act as tumor- suppressors and DN-isoforms that behave as proto-oncogenes.
    [Show full text]
  • Cellular and Developmental Control of O2 Homeostasis by Hypoxia-Inducible Factor 1␣
    Downloaded from genesdev.cshlp.org on September 28, 2021 - Published by Cold Spring Harbor Laboratory Press Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1a Narayan V. Iyer,1,5 Lori E. Kotch,1,5 Faton Agani,1 Sandra W. Leung,1 Erik Laughner,1 Roland H. Wenger,2 Max Gassmann,2 John D. Gearhart,3 Ann M. Lawler,3 Aimee Y. Yu,1 and Gregg L. Semenza1,4 1Center for Medical Genetics, Departments of Pediatrics and Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287-3914 USA; 2Institute of Physiology, University of Zurich-Irchel, 8057 Zurich, Switzerland; 3Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205 USA Hypoxia is an essential developmental and physiological stimulus that plays a key role in the pathophysiology of cancer, heart attack, stroke, and other major causes of mortality. Hypoxia-inducible factor 1 (HIF-1) is the only known mammalian transcription factor expressed uniquely in response to physiologically relevant levels −/− of hypoxia. We now report that in Hif1a embryonic stem cells that did not express the O2-regulated HIF-1a subunit, levels of mRNAs encoding glucose transporters and glycolytic enzymes were reduced, and cellular proliferation was impaired. Vascular endothelial growth factor mRNA expression was also markedly decreased in hypoxic Hif1a−/− embryonic stem cells and cystic embryoid bodies. Complete deficiency of HIF-1a resulted in developmental arrest and lethality by E11 of Hif1a−/− embryos that manifested neural tube defects, cardiovascular malformations, and marked cell death within the cephalic mesenchyme. In Hif1a+/+ embryos, HIF-1a expression increased between E8.5 and E9.5, coincident with the onset of developmental defects and cell death in Hif1a−/− embryos.
    [Show full text]
  • The MCK Enhancer Contains a P53 Responsive Element (P53/Anti-Oncogene/Trans-Activation) HAROLD WEINTRAUB*, STEPHEN Hauschkat, and STEPHEN J
    Proc. Natl. Acad. Sci. USA Vol. 88, pp. 4570-4571, June 1991 Biochemistry The MCK enhancer contains a p53 responsive element (p53/anti-oncogene/trans-activation) HAROLD WEINTRAUB*, STEPHEN HAUSCHKAt, AND STEPHEN J. TAPSCOTT* *Howard Hughes Medical Institute, Fred Hutchinson Cancer Research Center, 1124 Columbia Street, Seattle, WA 98104; and tDepartment of Biochemistry, University of Washington, Seattle, WA 98195 Contributed by Harold Weintraub, March 4, 1991 ABSTRACT p53 is an antioncogene that is defective or suggesting that activation may be species specific; however, absent in a large number of human tumors. Its function in levels ofprotein produced by the expression vectors were not normal cells is not known. We show that co-transfection of directly assayed in these experiments. By using an MCK- mouse p53 with muscle-specific creatine kinase-chloramphen- specific antibody, we have not been able to demonstrate icol acetyltransferase reporter gene, containing 3.3 kilobase of activation of the endogenous MCK gene in 10T1/2 cells upstream control sequence for the muscle-specfic creatine transfected with p53; in contrast 10T'/2 cells transfected with kinase gene, results in a 10- to 80-fold activation. The p53 MyoD express endogenous MCK immunoreactivity. responsive element maps to a region disinguhed from the Table 2 shows that a transforming mutant of murine p53 known MyoD binding region. Identification ofa p53 responsive (Ala -3 Val at position 135) fails to activate MCK-CAT in element should allow a more focused analysis of the effects of CV1 cells. A related mutation has lost its capacity for p53 in controlling gene activity. transactivation when fused to the DNA binding domain of GaI4 (5, 6).
    [Show full text]
  • Role of the Nuclear Receptor Rev-Erb Alpha in Circadian Food Anticipation and Metabolism Julien Delezie
    Role of the nuclear receptor Rev-erb alpha in circadian food anticipation and metabolism Julien Delezie To cite this version: Julien Delezie. Role of the nuclear receptor Rev-erb alpha in circadian food anticipation and metabolism. Neurobiology. Université de Strasbourg, 2012. English. NNT : 2012STRAJ018. tel- 00801656 HAL Id: tel-00801656 https://tel.archives-ouvertes.fr/tel-00801656 Submitted on 10 Apr 2013 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. UNIVERSITÉ DE STRASBOURG ÉCOLE DOCTORALE DES SCIENCES DE LA VIE ET DE LA SANTE CNRS UPR 3212 · Institut des Neurosciences Cellulaires et Intégratives THÈSE présentée par : Julien DELEZIE soutenue le : 29 juin 2012 pour obtenir le grade de : Docteur de l’université de Strasbourg Discipline/ Spécialité : Neurosciences Rôle du récepteur nucléaire Rev-erbα dans les mécanismes d’anticipation des repas et le métabolisme THÈSE dirigée par : M CHALLET Etienne Directeur de recherche, université de Strasbourg RAPPORTEURS : M PFRIEGER Frank Directeur de recherche, université de Strasbourg M KALSBEEK Andries
    [Show full text]
  • Androgen-Dependent Pathology Demonstrates Myopathic
    Research article Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model Zhigang Yu,1 Nahid Dadgar,1 Megan Albertelli,2 Kirsten Gruis,3 Cynthia Jordan,4 Diane M. Robins,2 and Andrew P. Lieberman1 1Department of Pathology, 2Department of Human Genetics, and 3Department of Neurology, University of Michigan Medical School, Ann Arbor, Michigan, USA. 4Department of Psychology and Neuroscience Program, Michigan State University, East Lansing, Michigan, USA. Kennedy disease, a degenerative disorder characterized by androgen-dependent neuromuscular weakness, is caused by a CAG/glutamine tract expansion in the androgen receptor (Ar) gene. We developed a mouse model of Kennedy disease, using gene targeting to convert mouse androgen receptor (AR) to human sequence while introducing 113 glutamines. AR113Q mice developed hormone and glutamine length–dependent neuromus- cular weakness characterized by the early occurrence of myopathic and neurogenic skeletal muscle pathology and by the late development of neuronal intranuclear inclusions in spinal neurons. AR113Q males unexpect- edly died at 2–4 months. We show that this androgen-dependent death reflects decreased expression of skeletal muscle chloride channel 1 (CLCN1) and the skeletal muscle sodium channel α-subunit, resulting in myotonic discharges in skeletal muscle of the lower urinary tract. AR113Q limb muscles show similar myopathic features and express decreased levels of mRNAs encoding neurotrophin-4 and glial cell line–derived neurotrophic fac- tor. These data define an important myopathic contribution to the Kennedy disease phenotype and suggest a role for muscle in non–cell autonomous toxicity of lower motor neurons. Introduction dent on the presence of androgen (13–16) and is regulated, in Kennedy disease, or spinal and bulbar muscular atrophy, is one part, by hormone-dependent retrograde transport (17, 18).
    [Show full text]
  • AP-1 in Cell Proliferation and Survival
    Oncogene (2001) 20, 2390 ± 2400 ã 2001 Nature Publishing Group All rights reserved 0950 ± 9232/01 $15.00 www.nature.com/onc AP-1 in cell proliferation and survival Eitan Shaulian1 and Michael Karin*,1 1Laboratory of Gene Regulation and Signal Transduction, Department of Pharmacology, University of California San Diego, 9500 Gilman Drive, La Jolla, California, CA 92093-0636, USA A plethora of physiological and pathological stimuli extensively discussed previously (Angel and Karin, induce and activate a group of DNA binding proteins 1991; Karin, 1995). that form AP-1 dimers. These proteins include the Jun, The mammalian AP-1 proteins are homodimers and Fos and ATF subgroups of transcription factors. Recent heterodimers composed of basic region-leucine zipper studies using cells and mice de®cient in individual AP-1 (bZIP) proteins that belong to the Jun (c-Jun, JunB proteins have begun to shed light on their physiological and JunD), Fos (c-Fos, FosB, Fra-1 and Fra-2), Jun functions in the control of cell proliferation, neoplastic dimerization partners (JDP1 and JDP2) and the closely transformation and apoptosis. Above all such studies related activating transcription factors (ATF2, LRF1/ have identi®ed some of the target genes that mediate the ATF3 and B-ATF) subfamilies (reviewed by (Angel eects of AP-1 proteins on cell proliferation and death. and Karin, 1991; Aronheim et al., 1997; Karin et al., There is evidence that AP-1 proteins, mostly those that 1997; Liebermann et al., 1998; Wisdom, 1999). In belong to the Jun group, control cell life and death addition, some of the Maf proteins (v-Maf, c-Maf and through their ability to regulate the expression and Nrl) can heterodimerize with c-Jun or c-Fos (Nishiza- function of cell cycle regulators such as Cyclin D1, p53, wa et al., 1989; Swaroop et al., 1992), whereas other p21cip1/waf1, p19ARF and p16.
    [Show full text]
  • Myod-Cre Driven Alterations in K-Ras and P53 Lead to a Mouse Model
    bioRxiv preprint doi: https://doi.org/10.1101/2021.06.15.448607; this version posted June 15, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. MyoD-Cre driven alterations in K-Ras and p53 lead to a mouse model with histological and molecular characteristics of human rhabdomyosarcoma with direct translational applications Kengo Nakahata1, Brian W. Simons2, Enrico Pozzo3, Ryan Shuck1, Lyazat Kurenbekova1, Cristian Coarfa4,6 Tajhal D. Patel1, and Jason T. Yustein*1,5,6 1Texas Children’s Cancer and Hematology Centers and The Faris D. Virani Ewing Sarcoma Center, Baylor College of Medicine, Houston, TX 77030 2Center for Comparative Medicine, Baylor College of Medicine, Houston, TX 77030 3Translational Cardiomyology Laboratory, Stem Cell Research Institute, Stem Cell Biology and Embryology Unit, Department of Development and Regeneration, KU Leuven, Leuven, Belgium. 4Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030 5Cancer and Cell Biology Program, Baylor College of Medicine, Houston, TX 77030 6Dan L. Duncan Cancer Comprehensive Center, Baylor College of Medicine, Houston, TX 77030 *Corresponding Author Corresponding Author: Jason T. Yustein, MD, PhD 1102 Bates St., Suite 1025.07 Houston, Texas 77030 832-824-4601 (Office) [email protected] ORCID: https://orcid.org/0000-0002-2052-0527 - 1 - bioRxiv preprint doi: https://doi.org/10.1101/2021.06.15.448607; this version posted June 15, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
    [Show full text]
  • Targeting the RB-E2F Pathway in Breast Cancer
    Oncogene (2016) 35, 4829–4835 © 2016 Macmillan Publishers Limited, part of Springer Nature. All rights reserved 0950-9232/16 www.nature.com/onc REVIEW Targeting the RB-E2F pathway in breast cancer J Johnson1, B Thijssen1, U McDermott2, M Garnett2, LFA Wessels1 and R Bernards1 Mutations of the retinoblastoma tumor-suppressor gene (RB1) or components regulating the CDK-RB-E2F pathway have been identified in nearly every human malignancy. Re-establishing cell cycle control through cyclin-dependent kinase (CDK) inhibition has therefore emerged as an attractive option in the development of targeted cancer therapy. The most successful example of this today is the use of the CDK4/6 inhibitor palbociclib combined with aromatase inhibitors for the treatment of estrogen receptor- positive breast cancers. Multiple studies have demonstrated that the CDK-RB-E2F pathway is critical for the control of cell proliferation. More recently, studies have highlighted additional roles of this pathway, especially E2F transcription factors themselves, in tumor progression, angiogenesis and metastasis. Specific E2Fs also have prognostic value in breast cancer, independent of clinical parameters. We discuss here recent advances in understanding of the RB-E2F pathway in breast cancer. We also discuss the application of genome-wide genetic screening efforts to gain insight into synthetic lethal interactions of CDK4/6 inhibitors in breast cancer for the development of more effective combination therapies. Oncogene (2016) 35, 4829–4835; doi:10.1038/onc.2016.32; published online 29 February 2016 INTRODUCTION multi-subunit protein complex containing partner (DP), RB-like, To maintain genome integrity, the mammalian cell cycle must be E2F and MuvB (DREAM) represses most if not all cell cycle gene 6 stringently regulated.
    [Show full text]